2017
Medical management of aortic disease in Marfan syndrome.
Bin Mahmood SU, Velasquez CA, Zafar MA, Saeyeldin AA, Brownstein AJ, Ziganshin BA, Elefteriades JA, Mukherjee SK. Medical management of aortic disease in Marfan syndrome. Annals Of Cardiothoracic Surgery 2017, 6: 654-661. PMID: 29270377, PMCID: PMC5721117, DOI: 10.21037/acs.2017.11.09.Peer-Reviewed Original ResearchAngiotensin receptor blockersMedical managementMarfan syndromeMFS patientsThoracic aortic aneurysm diseaseDifferent medical regimensStandard of careAortic aneurysm diseaseNumerous pathophysiological effectsAortic dilatationReceptor blockersAortic diseaseMedical regimensCurrent guidelinesAneurysm diseaseCardiovascular organsΒ-blockersCurrent evidencePathophysiological effectsHereditary disorderPatientsSyndromeDiseaseRegimensManagement
2015
Atenolol versus Losartan in Marfan's Syndrome
Ziganshin B, Mukherjee S, Elefteriades J. Atenolol versus Losartan in Marfan's Syndrome. New England Journal Of Medicine 2015, 372: 977-981. PMID: 25738681, DOI: 10.1056/nejmc1500128.Peer-Reviewed Original Research
2013
Do β-Blockers Really Work for Prevention of Aortic Aneurysms?
Chun AS, Elefteriades JA, Mukherjee SK. Do β-Blockers Really Work for Prevention of Aortic Aneurysms? Aorta 2013, 01: 45-51. PMID: 26798671, PMCID: PMC4682697, DOI: 10.12945/j.aorta.2013.13.002.Peer-Reviewed Original ResearchΒ-blockade therapyΒ-blocker treatmentAortic aneurysmMarfan syndromeClinical trialsMulticenter clinical trialSeparate clinical trialsScientific evidenceAdrenergic-blocking drugsAortic aneurysm growthAortic diseaseConventional therapyΒ-blockersGeneral populationPatientsAneurysmsSyndromeAneurysm growthTherapyTrialsTreatmentLiterature reviewDiseaseProgressionPrevention